News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,287 Results
Type
Article (87708)
Company Profile (824)
Press Release (777742)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233159)
Career Advice (4142)
Deals (39827)
Drug Delivery (144)
Drug Development (91340)
Employer Resources (203)
FDA (18341)
Job Trends (17414)
News (397659)
Policy (39945)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (164)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (299)
Approvals (18426)
Artificial intelligence (569)
Autoimmune disease (127)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (184)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (60)
Breast cancer (573)
Cancer (4552)
Cardiovascular disease (402)
Career advice (3564)
Career pathing (39)
CAR-T (282)
CDC (59)
Cell therapy (768)
Cervical cancer (36)
Clinical research (76360)
Collaboration (1556)
Company closure (5)
Compensation (1046)
Complete response letters (64)
COVID-19 (2973)
CRISPR (92)
C-suite (717)
Cystic fibrosis (146)
Data (5622)
Decentralized trials (2)
Denatured (67)
Depression (129)
Diabetes (489)
Diagnostics (7155)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (220)
Earnings (99865)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134391)
Executive appointments (1008)
FDA (21127)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1410)
Gene editing (199)
Generative AI (57)
Gene therapy (612)
GLP-1 (1077)
Government (5415)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (31)
Indications (71)
Infectious disease (3239)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17941)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (638)
Lymphoma (347)
Machine learning (37)
Management (66)
Manufacturing (724)
MASH (164)
Medical device (14958)
Medtech (14996)
Mergers & acquisitions (22854)
Metabolic disorders (1268)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (310)
Neuropsychiatric disorders (81)
Neuroscience (2921)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (603)
Opinion (324)
Ovarian cancer (151)
Pain (181)
Pancreatic cancer (195)
Parkinson's disease (264)
Partnered (34)
Patents (457)
Patient recruitment (385)
Peanut (58)
People (66575)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23572)
Phase II (33147)
Phase III (24975)
Pipeline (3674)
Policy (317)
Postmarket research (3554)
Preclinical (10646)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (779)
Real estate (7434)
Recruiting (80)
Regulatory (28458)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (22)
RNA editing (16)
RSV (82)
Schizophrenia (145)
Series A (228)
Series B (175)
Service/supplier (30)
Sickle cell disease (96)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1095)
Venture capital (76)
Weight loss (423)
Women's health (74)
Worklife (21)
Date
Today (187)
Last 7 days (783)
Last 30 days (2872)
Last 365 days (33472)
2025 (31823)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (51258)
Australia (9008)
California (10660)
Canada (3124)
China (1023)
Colorado (450)
Connecticut (477)
Delaware (319)
Europe (117863)
Florida (1564)
Georgia (344)
Hawaii (3)
Idaho (68)
Illinois (880)
India (61)
Indiana (511)
Iowa (22)
Japan (365)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1389)
Massachusetts (7918)
Michigan (337)
Minnesota (617)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (116)
New Hampshire (81)
New Jersey (2919)
New Mexico (32)
New York (2858)
North Carolina (1521)
North Dakota (10)
Northern California (4999)
Ohio (324)
Oklahoma (22)
Oregon (52)
Pennsylvania (2169)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4099)
Tennessee (164)
Texas (1666)
United States (38847)
Utah (320)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (898)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
There are 866,287 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
December 8, 2025
·
21 min read
Press Releases
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
December 8, 2025
·
10 min read
Press Releases
CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium
December 8, 2025
·
5 min read
Press Releases
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
December 8, 2025
·
5 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
Press Releases
Astrin Biosciences Announces Scientific Advisory Board to Advance Early Cancer Detection Leveraging AI and Proteomics
December 8, 2025
·
3 min read
Press Releases
Andelyn Biosciences Announces Partnership with Jaguar Gene Therapy to Provide Late-Stage PPQ Manufacturing
December 8, 2025
·
5 min read
Press Releases
EyeYon Medical Ltd. Receives FDA IDE Approval to Initiate U.S. Clinical Study of EndoArt®, the First Artificial Endothelial Layer for Corneal Edema
December 8, 2025
·
2 min read
Press Releases
Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH
December 8, 2025
·
3 min read
Press Releases
BioInvent Presents Impressive Response Data from Ongoing Phase 2a Trial of Triple Combination BI-1206, Rituximab, and Calquence in r/r NHL at ASH 2025
December 8, 2025
·
6 min read
1 of 86,629
Next
